Bristol Myers Squibb Announces Dividend

Rhea-AI Summary

Bristol Myers Squibb (BMY) declares quarterly dividends for common and preferred stockholders, with $0.60 per share for common stock and $0.50 per share for convertible preferred stock.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the $0.10 par value common stock of the company. The dividend is payable on May 1, 2024, to stockholders of record at the close of business on April 5, 2024.

In addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on June 3, 2024, to stockholders of record at the close of business on May 7, 2024.

About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20240301262898/en/

Media:

media@bms.com

Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

What dividend has Bristol Myers Squibb (BMY) declared for its common stock?

Bristol Myers Squibb has declared a quarterly dividend of $0.60 per share for its common stock.

When will the dividend for Bristol Myers Squibb's common stock be payable?

The dividend for Bristol Myers Squibb's common stock will be payable on May 1, 2024.

How much is the dividend for Bristol Myers Squibb's convertible preferred stock?

Bristol Myers Squibb has declared a quarterly dividend of $0.50 per share for its convertible preferred stock.

When will the dividend for Bristol Myers Squibb's convertible preferred stock be payable?

The dividend for Bristol Myers Squibb's convertible preferred stock will be payable on June 3, 2024.